| Gregory L Charlop, MD | |
|
3645 High Green Dr, Marietta, GA 30068-2530 | |
| (650) 281-1297 | |
| Not Available |
| Full Name | Gregory L Charlop |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 24 Years |
| Location | 3645 High Green Dr, Marietta, Georgia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1558449355 | NPI | - | NPPES |
| 00A761960 | Medicaid | CA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | S9275 (Texas) | Secondary |
| 207L00000X | Anesthesiology | 89911 (Georgia) | Secondary |
| 207L00000X | Anesthesiology | A76196 (California) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Orthomed Staffing Llc | 9638429178 | 237 |
| Orthomed Staffing Llc | 9638429178 | 237 |
News Archive
A new investigational device - the Helio System (TF-FA) - being developed for use with the Sapien XT Transcatheter Heart Valve was successfully deployed in all four patients in a small, first-in-human feasibility study of its use in high-risk aortic insufficiency reported at EuroPCR 2013.
The promise of stem cells to treat cardiovascular disease may soon be a step closer to clinical application as scientists from three institutions seek to perfect and test three-dimensional "heart patches" in a large animal model — the last big hurdle before trials in human patients.
Pfizer Inc. today released detailed information about how and why the company works with a range of healthcare professionals and researchers to advance patient care and develop lifesaving medicines. The information reflects payments or exchanges of value received by licensed U.S. healthcare professionals who consulted with Pfizer about the development and marketing of new medicines and helped to educate other healthcare professionals about the safe and appropriate use of its products.
This World No Tobacco Day, Ontario's doctors are calling for renewed efforts to reduce the total number of smokers in Ontario. While the current government has shown leadership by implementing a number of initiatives to help reduce the use of tobacco and second hand smoke, there is still more work to be done.
Despite an expert panel stating last month that the three COX-2 drugs Vioxx, Bextra and Celebrex were safe enough to be marketed, the U.S. Food and Drug Administration (FDA) has this week told drug manufacturer Pfizer to remove the drug Bextra from the market and a statement by Pfizer confirms that the European Union regulators have done the same.
› Verified 9 days ago
| Entity Name | Orthomed Staffing Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1225514276 PECOS PAC ID: 9638429178 Enrollment ID: O20180905000794 |
News Archive
A new investigational device - the Helio System (TF-FA) - being developed for use with the Sapien XT Transcatheter Heart Valve was successfully deployed in all four patients in a small, first-in-human feasibility study of its use in high-risk aortic insufficiency reported at EuroPCR 2013.
The promise of stem cells to treat cardiovascular disease may soon be a step closer to clinical application as scientists from three institutions seek to perfect and test three-dimensional "heart patches" in a large animal model — the last big hurdle before trials in human patients.
Pfizer Inc. today released detailed information about how and why the company works with a range of healthcare professionals and researchers to advance patient care and develop lifesaving medicines. The information reflects payments or exchanges of value received by licensed U.S. healthcare professionals who consulted with Pfizer about the development and marketing of new medicines and helped to educate other healthcare professionals about the safe and appropriate use of its products.
This World No Tobacco Day, Ontario's doctors are calling for renewed efforts to reduce the total number of smokers in Ontario. While the current government has shown leadership by implementing a number of initiatives to help reduce the use of tobacco and second hand smoke, there is still more work to be done.
Despite an expert panel stating last month that the three COX-2 drugs Vioxx, Bextra and Celebrex were safe enough to be marketed, the U.S. Food and Drug Administration (FDA) has this week told drug manufacturer Pfizer to remove the drug Bextra from the market and a statement by Pfizer confirms that the European Union regulators have done the same.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Gregory L Charlop, MD 3645 High Green Dr, Marietta, GA 30068-2530 Ph: (650) 281-1297 | Gregory L Charlop, MD 3645 High Green Dr, Marietta, GA 30068-2530 Ph: (650) 281-1297 |
News Archive
A new investigational device - the Helio System (TF-FA) - being developed for use with the Sapien XT Transcatheter Heart Valve was successfully deployed in all four patients in a small, first-in-human feasibility study of its use in high-risk aortic insufficiency reported at EuroPCR 2013.
The promise of stem cells to treat cardiovascular disease may soon be a step closer to clinical application as scientists from three institutions seek to perfect and test three-dimensional "heart patches" in a large animal model — the last big hurdle before trials in human patients.
Pfizer Inc. today released detailed information about how and why the company works with a range of healthcare professionals and researchers to advance patient care and develop lifesaving medicines. The information reflects payments or exchanges of value received by licensed U.S. healthcare professionals who consulted with Pfizer about the development and marketing of new medicines and helped to educate other healthcare professionals about the safe and appropriate use of its products.
This World No Tobacco Day, Ontario's doctors are calling for renewed efforts to reduce the total number of smokers in Ontario. While the current government has shown leadership by implementing a number of initiatives to help reduce the use of tobacco and second hand smoke, there is still more work to be done.
Despite an expert panel stating last month that the three COX-2 drugs Vioxx, Bextra and Celebrex were safe enough to be marketed, the U.S. Food and Drug Administration (FDA) has this week told drug manufacturer Pfizer to remove the drug Bextra from the market and a statement by Pfizer confirms that the European Union regulators have done the same.
› Verified 9 days ago
Donald R Taylor, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 840 Church Street, Suite B, Marietta, GA 30060 Phone: 770-421-8080 Fax: 770-421-9566 | |
Ashkan Yazdanpanah, DO Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 677 Church St Ne, Marietta, GA 30060 Phone: 770-794-0477 Fax: 770-794-3108 | |
Thomas M Adair, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 677 Church St Ne, Marietta, GA 30060 Phone: 770-794-0477 | |
Dr. Stuart E Cohen, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 2540 Windy Hill Rd Se, Marietta, GA 30067 Phone: 470-644-1274 Fax: 470-644-1119 | |
Dr. William Shearin Jr., M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 4048 Penhurst Dr, Marietta, GA 30062 Phone: 770-579-3650 | |
Alson Mercurius, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 677 Church St Ne, Marietta, GA 30060 Phone: 770-794-0477 Fax: 770-794-3108 | |
Armando Janeira, MD Anesthesiology Medicare: Medicare Enrolled Practice Location: 531 Roselane St Nw, Suite 750, Marietta, GA 30060 Phone: 770-794-0477 Fax: 770-794-3108 |